Alcon’s Neurotech Prescribed drugs acquisition brings the uncommon imaginative and prescient dysfunction cell remedy Encelto in addition to the platform know-how that developed it. Final yr, Alcon acquired a majority stake in Aurion Biotech, a startup creating a corneal cell remedy.
The publish Alcon Expands Its Cell Remedy Ambitions With $550M Neurotech Pharma Acquisition appeared first on MedCity Information.

